CARNA BIOSCIENCES, INC. · カルナバイオサイエンス株式会社
Last · —¥337.00-6.00 (-1.75%)live · yahoo · 1s ago
Market cap¥7.1B21.2M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
¥202.00¥497.00
Volume138.7Ksession
| Revenue | ¥579.1M |
|---|---|
| Operating income | ¥-2.1B |
| Net income | ¥-2.2B |
| Free cash flow | ¥-2.2B |
| Operating margin | -358.3% |
| Net margin | -375.0% |
| Return on equity | -941.4% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-26
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.2 years
- Accumulated Deficit High — Accumulated deficit / equity 641%
- Rd Intensity High — R&D/Revenue 319.7%
Documents
FormReporting forFiledFlags